KDR and neoplasm: Systemic delivery of VEGFR-2 and PLXDC1 siRNA to tumor endothelium reduced tumor burden [126, 127], and STAT3 siRNA directed to bone marrow endothelium in a model of bone metastasis prolonged survival in tumor-bearing mice [128].